...
首页> 外文期刊>International Journal of Pharmaceutics >Protein encapsulated core-shell structured particles prepared by coaxial electrospraying: Investigation on material and processing variables
【24h】

Protein encapsulated core-shell structured particles prepared by coaxial electrospraying: Investigation on material and processing variables

机译:同轴电喷雾制备的蛋白质包封的核壳结构颗粒:材料和加工变量的研究

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Biodegradable polymeric particles have been extensively investigated for controlled drug delivery of various therapeutic agents. 'Coaxial' electrospraying was successfully employed in this study, to fabricate core-shell PLGA particles containing bovine serum albumin (BSA) as the model protein, and the results were also compared to particles prepared by 'emulsion' electrospraying. Two different molecular weights of PLGA were employed to encapsulate the protein. Solution properties and processing parameters were found to influence the morphology of the core-shell particles. Depending on the type of solvent used to dissolve the polymer as well as the polymer concentration and molecular weight, the mean diameter of the particles varied between 3.0 to 5.5 ? Fluorescence microscopic analysis of the electrosprayed particles using FITC-conjugated BSA demonstrated the core-shell structure of the developed particles. The encapsulation efficiency and release behavior of BSA was influenced by shell:core feeding ratio, protein concentration, and the electrospraying method. The encapsulation efficiency of BSA within the core-shell particles of high and low molecular weight PLGA was found 15.7% and 25.1% higher than the emulsion electrosprayed particles, respectively. Moreover, the total amount of BSA released from low molecular weight PLGA particles was significantly higher than high molecular weight PLGA particles within 43 days of release studies, with negligible effect on encapsulation efficiency. The technique of coaxial electrospraying has high potential for encapsulation of susceptible protein-based therapeutic agents such as growth factors for multiple drug delivery applications.
机译:已经对可生物降解的聚合物颗粒进行了广泛研究,以控制各种治疗剂的药物递送。在这项研究中成功地使用了“同轴”电喷涂技术,以制备包含牛血清白蛋白(BSA)作为模型蛋白的核-壳PLGA颗粒,并将结果与​​通过“乳液”电喷涂制备的颗粒进行了比较。两种不同分子量的PLGA被用来包裹蛋白质。发现溶液性质和加工参数影响核-壳颗粒的形态。取决于用于溶解聚合物的溶剂类型以及聚合物的浓度和分子量,颗粒的平均直径在3.0到5.5?之间变化。使用FITC共轭BSA进行的电喷涂颗粒的荧光显微镜分析表明,所开发颗粒的核壳结构。 BSA的包封效率和释放行为受壳:芯进料比,蛋白质浓度和电喷雾方法的影响。发现BSA在高和低分子量PLGA的核-壳粒子中的包封效率分别比乳液电喷雾粒子高15.7%和25.1%。而且,在释放研究的43天内,从低分子量PLGA颗粒释放的BSA的总量显着高于高分子量PLGA颗粒,对包封效率的影响可以忽略。同轴电喷雾技术具有封装潜在的基于蛋白质的治疗剂(例如用于多种药物递送应用的生长因子)的高潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号